humanized monoclonal antibody (Shihuida Pharmaceutical Group)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehumanized monoclonal antibody (Shihuida Pharmaceutical Group)
Drug Alias Namehumanized monoclonal antibody (Jilin Kanghui Biotechnology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShihuida Pharmaceutical Group (Jilin) ​​Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShihuida Pharmaceutical Group (Jilin) ​​Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A